1: Megat S, Ray PR, Moy JK, Lou TF, Barragan-Iglesias P, Li Y, Pradhan G,
Wanghzou A, Ahmad A, Burton MD, North RY, Dougherty PM, Khoutorsky A, Sonenberg
N, Webster KR, Dussor G, Campbell ZT, Price TJ. Nociceptor translational
profiling reveals the Ragulator-Rag GTPase complex as a critical generator of
neuropathic pain. J Neurosci. 2018 Nov 20. pii: 2661-18. doi:
10.1523/JNEUROSCI.2661-18.2018. [Epub ahead of print] PubMed PMID: 30459229.
2: Reich SH, Sprengeler PA, Chiang GG, Appleman JR, Chen J, Clarine J, Eam B,
Ernst JT, Han Q, Goel VK, Han EZR, Huang V, Hung INJ, Jemison A, Jessen KA,
Molter J, Murphy D, Neal M, Parker GS, Shaghafi M, Sperry S, Staunton J, Stumpf
CR, Thompson PA, Tran C, Webber SE, Wegerski CJ, Zheng H, Webster KR.
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated
Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1
and 2 (MNK1/2) Inhibition. J Med Chem. 2018 Apr 26;61(8):3516-3540. doi:
10.1021/acs.jmedchem.7b01795. Epub 2018 Mar 29. PubMed PMID: 29526098.
3: Dreas A, Mikulski M, Milik M, Fabritius CH, Brzózka K, Rzymski T.
Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and
MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK
Inhibitors. Curr Med Chem. 2017;24(28):3025-3053. doi:
10.2174/0929867324666170203123427. Review. PubMed PMID: 28164761.
